Transasia BioMedicals weighs stake sale to raise up to $200 million
In short
Transasia BioMedicals is exploring a sale of up to 20% of the company to raise $150 million to $200 million. TPG, Warburg Pincus, ChrysCapital and others are said to be looking at the deal.
A successful sale would support its funding plans.
What the reporting says
Transasia BioMedicals is exploring a minority stake sale of up to 20% to raise $150 million to $200 million, according to the report. TPG, Warburg Pincus, ChrysCapital and others are looking at the opportunity. The move would bring in fresh capital for the medical equipment maker if a deal is completed.
Why it matters
Transasia BioMedicals is seeking $150 million to $200 million through a minority stake sale of up to 20%. The reported interest includes TPG, Warburg Pincus and ChrysCapital, among others. The potential deal would raise capital for the medical equipment maker and could reshape its ownership structure if completed.